Hostname: page-component-89b8bd64d-ktprf Total loading time: 0 Render date: 2026-05-11T06:36:17.800Z Has data issue: false hasContentIssue false

Imagery-Focused Cognitive Therapy (ImCT) for Mood Instability and Anxiety in a Small Sample of Patients with Bipolar Disorder: a Pilot Clinical Audit

Published online by Cambridge University Press:  09 July 2018

Susie A. Hales*
Affiliation:
Oxford Institute of Clinical Psychology Training, Oxford, UK
Martina Di Simplicio
Affiliation:
Centre for Psychiatry, Brain Sciences Division, Imperial College London, London, UK MRC Cognition and Brain Sciences Unit, Cambridge, UK
Lalitha Iyadurai
Affiliation:
Department of Psychiatry, University of Oxford and Oxford Health NHS Foundation Trust, UK
Simon E. Blackwell
Affiliation:
Ruhr Universität-Bochum, Bochum, Germany
Kerry Young
Affiliation:
Central and North West London NHS Foundation Trust, UK
Christopher G. Fairburn
Affiliation:
Department of Psychiatry, University of Oxford and Oxford Health NHS Foundation Trust, UK
John R. Geddes
Affiliation:
Department of Psychiatry, University of Oxford; NIHR Oxford Health Biomedical Research Centre and Oxford Health NHS Foundation Trust, UK
Guy M. Goodwin
Affiliation:
Department of Psychiatry, University of Oxford and Oxford Health NHS Foundation Trust, UK
Emily A. Holmes
Affiliation:
Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
*
Correspondence to Susie A. Hales, Oxford Institute of Clinical Psychology Training, Oxford, UK. E-mail: susie.hales@hmc.ox.ac.uk

Abstract

Background: Despite the global impact of bipolar disorder (BD), treatment success is limited. Challenges include syndromal and subsyndromal mood instability, comorbid anxiety, and uncertainty around mechanisms to target. The Oxford Mood Action Psychology Programme (OxMAPP) offered a novel approach within a cognitive behavioural framework, via mental imagery-focused cognitive therapy (ImCT). Aims: This clinical audit evaluated referral rates, clinical outcomes and patient satisfaction with the OxMAPP service. Method: Eleven outpatients with BD received ImCT in addition to standard psychiatric care. Mood data were collected weekly from 6 months pre-treatment to 6 months post-treatment via routine mood monitoring. Anxiety was measured weekly from start of treatment until 1 month post-treatment. Patient feedback was provided via questionnaire. Results: Referral and treatment uptake rates indicated acceptability to referrers and patients. From pre- to post-treatment, there was (i) a significant reduction in the duration of depressive episode relapses, and (ii) a non-significant trend towards a reduction in the number of episodes, with small to medium effect size. There was a large effect size for the reduction in weekly anxiety symptoms from assessment to 1 month follow-up. Patient feedback indicated high levels of satisfaction with ImCT, and underscored the importance of the mental imagery focus. Conclusions: This clinical audit provides preliminary evidence that ImCT can help improve depressive and anxiety symptoms in BD as part of integrated clinical care, with high patient satisfaction and acceptability. Formal assessment designs are needed to further test the feasibility and efficacy of the new ImCT treatment on anxiety and mood instability.

Information

Type
Research Article
Copyright
Copyright © British Association for Behavioural and Cognitive Psychotherapies 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Submit a response

Comments

No Comments have been published for this article.